Centene (CNC) Financial Analysis & Valuation | Quarter Chart
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, ... more
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and se... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $34.66B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Healthcare Plans |
| Country | US | CEO | Sarah McGinty London |
| IPO Date | 2001-12-13 | CAGR | 30.26% |
| Employees | 61,100 | Website | www.centene.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.04% | Total Yield | 0.04% |
CNC chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $27.25B | P/E | 27.85 | Forward P/E | 13.12 | PEG | — |
| P/S | 2.06 | P/B | 17.56 | P/CF | 39.94 | P/FCF | 43.95 |
| Sales | $193.73B | Sales 1Y | 8.72% | Sales 3Y | 30.97% | Sales 5Y | 63.65% |
| EPS | $2.52 | EPS 1Y | -358.42% | EPS 3Y | -315.7% | EPS 5Y | -956.23% |
| Sales QoQ | -11.15% | EPS QoQ | -29.58% | Sales QoQ Avg | -2.17% | EPS QoQ Avg | 548.81% |
| Gross Margin | 19.93% | Operating Margin | -2.78% | Profit Margin | -2.51% | ROCE | -13.34% |
| ROA | -6% | ROE | -24% | Altman Z Score | 2.9 | Piotroski Score | 6 |
| Current Ratio | 1.15 | Quick Ratio | 1.15 | Cash Ratio | 0.59 | Op. CF Ratio | 0.11 |
| Debt/Equity | 0.71 | Debt/Assets | 0.19 | Lt Debt/Equity | 0.71 | Lt Debt/Cap. | 0.42 |
| Intrst Cov. | -16.15 | Inventory Turnover | — | Asset Turnover | 2.44 | Receivables Turnover | — |
| Enterprise Value | $27.25B | P/E Ratio | 27.85 |
| Forward P/E | 13.12 | PEG Ratio | — |
| P/S Ratio | 2.06 | P/B Ratio | 17.56 |
| P/CF Ratio | 39.94 | P/FCF Ratio | 43.95 |
| EPS | $2.52 | EPS Growth 1Y | -358.42% |
| EPS Growth 3Y | -315.7% | EPS Growth 5Y | -956.23% |
| Revenue Growth 1Y | 8.72% | Gross Margin | 19.93% |
| Operating Margin | -2.78% | Profit Margin | -2.51% |
| ROE | -24% | ROA | -6% |
| ROCE | -13.34% | Current Ratio | 1.15 |
| Quick Ratio | 1.15 | Cash Ratio | 0.59 |
| Debt/Equity | 0.71 | Interest Coverage | -16.15 |
| Altman Z Score | 2.9 | Piotroski Score | 6 |
Centene (CNC) valuation & financials
Centene (CNC) has a market capitalization of $34.66B and trades at a price-to-earnings ratio of 27.9. It operates in the Healthcare sector (Medical - Healthcare Plans).
Centene's revenue grew +8.7% over the last year.
Centene's next earnings report is scheduled for October 27, 2026 before market open (provider scheduled date); analysts estimate EPS of $0.10. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)